Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Open accessAbstract
Many functions have been assigned to the von Hippel-Lindau tumor suppressor gene product (pVHL), including targeting the alpha subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for destruction. The binding of pVHL to HIFalpha requires that HIFalpha be hydroxylated on one of two prolyl residues. We introduced HIF1alpha and HIF2alpha variants that cannot be hydroxylated on these sites into the ubiquitously expressed ROSA26 locus along with a Lox-stop-Lox cassette that renders their expression Cre-dependent. Expression of the HIF2alpha variant in the skin and liver induced changes that were highly similar to those seen when pVHL is lost in these organs. Dual expression of the HIF1alpha and HIF2alpha variants in liver, however, more closely phenocopied the changes seen after pVHL inactivation than did the HIF2alpha variant alone. Moreover, gene expression profiling confirmed that the genes regulated by HIF1alpha and HIF2alpha in the liver are overlapping but non-identical. Therefore, the pathological changes caused by pVHL inactivation in skin and liver are due largely to dysregulation of HIF target genes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Over-expression of non-degradable HIF-2α in hepatocytes produced erythrocytosis, whereas over-expression of HIF-1α did not.
“Over-expression of non-degradable HIF-2α in hepatocytes produced erythrocytosis, whereas over-expression of HIF-1α did not. 110”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · see citing works
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,185 · see citing works
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · see citing works
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237 · see citing works
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · see citing works
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121 · see citing works
Cellular and developmental control of O <sub>2</sub> homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · see citing works
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · see citing works
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386 · see citing works
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. T., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,350 · see citing works
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302 · see citing works
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed Central · Cited by 1,099 · see citing works
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,053 · see citing works
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · see citing works
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967 · see citing works
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works
Role of VHL Gene Mutation in Human Cancer
Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 940 · see citing works
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 882 · see citing works
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865 · see citing works
Self-citationZambrowicz, B., Imamoto, A., Fiering, S., Herzenberg, L. A., Kerr, W. G., & Soriano, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3789 · Cited by 850 · see citing works
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761 · see citing works
Self-citationCompernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F., et al. (2002) · Nature Medicine · doi:10.1038/nm721 · Cited by 733 · see citing works
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
Isaacs, J. S., Jung, Y.-J., Mimnaugh, E. G., Martinez, A., Cuttitta, F., & Neckers, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204733200 · Cited by 663 · see citing works
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647 · see citing works
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611 · see citing works
Gnarra, J. R., Zhou, S., Merrill, M. J., WAGNER, J. R., Krumm, A., Papavassiliou, E. D., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 528 · see citing works
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1019 · Cited by 510 · see citing works
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483 · see citing works
Peng, J., Zhang, L., Drysdale, L., & Fong, G.-H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140087397 · Cited by 460 · cited 1× · see citing works
“HIF2a / mice also exhibit embryonic or early postnatal lethality but as a consequence of catechola- mine deficiency or lung maturation defects (Tian et al, 1998; Peng et al, 2000; Compernolle et al, 2002).”
BackgroundMaranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 433 · see citing works
Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressor
Haase, V. H., Glickman, J. N., Socolovsky, M., & Jaenisch, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1583 · Cited by 421 · see citing works
Hoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382 · see citing works
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
Gnarra, J. R., Ward, J. M., Porter, F. D., WAGNER, J. R., Devor, D. E., Grinberg, A., Emmert‐Buck, M. R., Westphal, H., Klausner, R. D., & Linehan, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9102 · Cited by 362 · see citing works
Signalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 343 · see citing works
Vincent, K. A., Shyu, K., Luo, Y., Magner, M., Tio, R. A., Jiang, C., Goldberg, M. A., Akita, G. Y., Gregory, R. J., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.18.2255 · Cited by 314 · see citing works
Wang, V., Davis, D. A., Haque, M., Huang, E. L., & Yarchoan, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4130 · Cited by 309 · see citing works
Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny‐Baron, G., & Marmé, D. (1996) · PubMed · Cited by 309 · see citing works
Elson, D. A., Thurston, G., Huang, E. L., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 297 · see citing works
Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain
Mao, X., Fujiwara, Y., Chapdelaine-Williams, A. M., Yang, H., & Orkin, S. H. (2001) · Blood · doi:10.1182/blood.v97.1.324 · Cited by 291 · see citing works
Gordeuk, V. R., Sergueeva, A. I., Miasnikova, G. Y., Okhotin, D., Voloshin, Y., Choyke, P. L., Butman, J. A., Jedlickova, K., Prchal, J. T., & Polyakova, L. A. (2004) · Blood · doi:10.1182/blood-2003-07-2535 · Cited by 273 · see citing works
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 263 · see citing works
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors
Zimmer, M., Doucette, D., Siddiqui, N., & Iliopoulos, O. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.89.2.2 · Cited by 244 · see citing works
Compernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F., et al. (2002) · Nature Medicine · doi:10.1038/nm1102-1329b · Cited by 237 · see citing works
Larcher, F., Murillas, R., Bolontrade, M. F., Conti, C. J., & Jorcano, J. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201928 · Cited by 231 · see citing works
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 213 · see citing works
Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors
Aprelikova, O. N., Chandramouli, G. V. R., Wood, M. J. A., Vasselli, J. R., Riss, J., Maranchie, J. K., Linehan, W. M., & Barrett, J. C. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20067 · Cited by 212 · see citing works
Zatyka, M., da Silva, N. F., Clifford, S. C., Morris, M. R., Wiesener, M. S., Eckardt, K., Houlston, R. S., Richards, F. M., Latif, F., & Maher, E. R. (2002) · PubMed · doi:10.25405/ncl.34582002 · Cited by 147 · see citing works
Rankin, E. B., Higgins, D. F., Walisser, J. A., Johnson, R. S., Bradfield, C. A., & Haase, V. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3163-3172.2005 · Cited by 137 · see citing works
Mutations in the VHL gene in sporadic apparently congenital polycythemia
Pastore, Y. D., Jelinek, J., Ang, S., Guan, Y., Liu, E., Jedlickova, K., Krishnamurti, L., & Prchal, J. T. (2003) · Blood · doi:10.1182/blood-2002-06-1843 · Cited by 136 · see citing works
Jiang, Y., Zhang, W., Kondo, K., Klco, J. M., Martin, T. B. S., Dufault, M. R., Madden, S. F., Kaelin, W. G., & Nacht, M. (2003) · PubMed · Cited by 124 · see citing works
Covello, K. L., Simon, M. C., & Keith, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3246 · Cited by 121 · see citing works
Ma, W., Tessarollo, L., Hong, S., Baba, M., Southon, E. A., Back, T. C., Spence, S. E., Lobe, C. G., Sharma, N. D., Maher, G., et al. (2003) · PubMed · Cited by 112 · see citing works
Wykoff, C. C., Sotiriou, C. P., Cockman, M. E., Ratcliffe, P. J., Maxwell, P. H., Liu, E., & Harris, A. L. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601657 · Cited by 99 · see citing works
Putative Control of Angiogenesis in Hemangioblastomas by the von Hippel-Lindau Tumor Suppressor Gene
Stratmann, R., Krieg, M., HAAS, R., & Plate, K. H. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00009 · Cited by 81 · see citing works
von Hippel–Lindau tumor suppressor: not only HIF's executioner
Czyzyk-Krzeska, M., & Meller, J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.02.004 · Cited by 70 · see citing works
Targeted Somatic Mutagenesis in Mouse Epidermis
Indra, A. K., Li, M., Brocard, J., Warot, X. M., Bornert, J., Gérard, C., Messaddeq, N., Chambon, P., & METZGER, D. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053275 · Cited by 65 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hypoxia-Induced Angiogenesis: Good and Evil
Krock, B. L., Skuli, N., & Simon, M. C. (2011) · Genes & Cancer · doi:10.1177/1947601911423654 · Cited by 1,179 · see citing works
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941 · see citing works
Regulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787 · see citing works
VHL, the story of a tumour suppressor gene
Gossage, L., Eisen, T. G., & Maher, E. R. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3844 · Cited by 777 · see citing works
Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S. R., Bouxsein, M., Monier‐Faugere, M., Guldberg, R. E., Gerstenfeld, L. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31581 · Cited by 735 · see citing works
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin, W. G. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2502 · Cited by 731 · see citing works
Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658 · see citing works
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
Chakraborty, A. A., Laukka, T., Myllykoski, M., Ringel, A. E., Booker, M. A., Tolstorukov, M. Y., Meng, Y. J., Meier, S. R., Jennings, R. B., Creech, A. L., et al. (2019) · Science · doi:10.1126/science.aaw1026 · Cited by 432 · see citing works
Genetic and Functional Studies Implicate <i>HIF1</i> α as a 14q Kidney Cancer Suppressor Gene
Shen, C., Beroukhim, R., Schumacher, S. E., Zhou, J., Chang, M., Signoretti, S., & Kaelin, W. G. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0098 · Cited by 413 · see citing works
Regulation of Angiogenesis by Oxygen and Metabolism
Fraisl, P., Mazzone, M., Schmidt, T., & Carmeliet, P. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.003 · Cited by 409 · see citing works
Qiu, B., Ackerman, D., Sanchez, D. J., Li, B., Ochocki, J. D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., & Simon, M. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1507 · Cited by 394 · see citing works
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 387 · see citing works
Human high-altitude adaptation: forward genetics meets the HIF pathwayPreprint
Bigham, A. W., & Lee, F. S. (2014) · Genes & Development · doi:10.1101/gad.250167.114 · Cited by 350 · see citing works
Hypoxic regulation of erythropoiesis and iron metabolism
Haase, V. H. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00174.2010 · Cited by 347 · see citing works
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Wallace, E. M., Rizzi, J. P., Han, G., Wehn, P. M., Cao, Z., Du, X., Cheng, T., Czerwinski, R. M., Dixon, D. D., Goggin, B. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0473 · Cited by 336 · see citing works
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
Kaelin, W. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1865 · Cited by 336 · see citing works
Self-citationHypoxia-inducible factors and the regulation of lipid metabolism
Mylonis, I., Simos, G., & Paraskeva, E. (2019) · Cells · doi:10.3390/cells8030214 · Cited by 316 · see citing works
VHL and HIF signalling in renal cell carcinogenesis
Baldewijns, M. M. L. L., van Vlodrop, I. J. H., Vermeulen, P. B., Soetekouw, P. M. M. B., van Engeland, M., & A, A. P. D. B. (2010) · The Journal of Pathology · doi:10.1002/path.2689 · Cited by 317 · see citing works
A Gain-of-Function Mutation in the <i>HIF2A</i> Gene in Familial Erythrocytosis
Percy, M. J., Furlow, P. W., Lucas, G. S., Li, X., Lappin, T. R. J., McMullin, M. F., & Lee, F. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073123 · Cited by 314 · see citing works
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298 · see citing works
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288 · see citing works
Hypoxia and Hypoxia Inducible Factors: Diverse Roles in Liver Diseases
Nath, B., & Szabó, G. (2011) · Hepatology · doi:10.1002/hep.25497 · Cited by 290 · see citing works
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., & Kaelin, W. G. (2008) · Nature Cell Biology · doi:10.1038/ncb1699 · Cited by 239 · see citing works
Takeda, K., Cowan, A., & Fong, G.-H. (2007) · Circulation · doi:10.1161/circulationaha.107.701516 · Cited by 236 · see citing works
Hypoxia-inducible factors and their roles in energy metabolism
Goda, N., & Kanai, M. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1069-y · Cited by 213 · see citing works
Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis
Basten, S. G., & Giles, R. H. (2013) · Cilia · doi:10.1186/2046-2530-2-6 · Cited by 209 · see citing works
HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
Elorza, A., Soro-Arnáiz, I., Meléndez‐Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta‐Iborra, B., Albacete-Albacete, L., Ordóñez, Á., Serrano‐Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 206 · see citing works
Wilson, G. K., Tennant, D. A., & McKeating, J. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.025 · Cited by 201 · see citing works
Mechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 201 · see citing works
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
Han, X., Li, F., Fang, Z., Gao, Y., Li, F., Fang, R., Yao, S., Sun, Y., Li, L., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms4261 · Cited by 193 · see citing works
Yan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01514-06 · Cited by 193 · see citing works
Regulation of endocytosis via the oxygen-sensing pathway
Wang, Y., Roche, O., Yan, M. S., Finak, G., Evans, A. J., Metcalf, J. L., Hast, B. E., Hanna, S. C., Wondergem, B., Furge, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1922 · Cited by 193 · see citing works
Nath, B., Levin, I., Csák, T., Petrasek, J., Mueller, C. A., Kodys, K., Catalano, D. E., Mandrekar, P., & Szabó, G. (2011) · Hepatology · doi:10.1002/hep.24256 · Cited by 189 · see citing works
The VHL tumor suppressor: master regulator of HIF
Haase, V. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649394 · Cited by 175 · see citing works
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
Yang, H., Minamishima, Y. A., Yan, Q., Schlisio, S., Ebert, B. L., Zhang, X., Zhang, L., Kim, W. Y., Olumi, A. F., & Kaelin, W. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.010 · Cited by 179 · see citing works
The HIF pathway and erythrocytosis
Lee, F. S., & Percy, M. J. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130321 · Cited by 177 · see citing works
Epidermal Sensing of Oxygen Is Essential for Systemic Hypoxic Response
Boutin, A. T., Weidemann, A., Fu, Z., Mesropian, L., Gradin, K., Jamora, C., Wiesener, M. S., Eckardt, K., Koch, C. J., Ellies, L. G., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.038 · Cited by 177 · see citing works
Xue, X., Ramakrishnan, S. K., Anderson, E. R., Taylor, M. J., Zimmermann, E. M., Spence, J. R., Huang, S., Greenson, J. K., & Shah, Y. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.010 · Cited by 171 · see citing works
Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer
Kaelin, W. G. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162480 · Cited by 178 · see citing works
Moslehi, J. J., Minamishima, Y. A., Shi, J., Neuberg, D. S., Charytan, D. M., Padera, R. F., Signoretti, S., Liao, R., & Kaelin, W. G. (2010) · Circulation · doi:10.1161/circulationaha.109.922427 · Cited by 168 · see citing works
Hif-2α Promotes Degradation of Mammalian Peroxisomes by Selective Autophagy
Walter, K., Schönenberger, M. J., Trötzmüller, M., Horn, M., Elsässer, H., Moser, A. B., Lucas, M. S., Schwarz, T., Gerber, P. A., Faust, P. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.017 · Cited by 164 · see citing works
Reactivation of hepatic EPO synthesis in mice after PHD loss
Minamishima, Y. A., & Kaelin, W. G. (2010) · Science · doi:10.1126/science.1192811 · Cited by 163 · see citing works
State of the Science: An Update on Renal Cell Carcinoma
Jonasch, E. W., Futreal, P. A., Davis, I. J., Bailey, S. T., Kim, W. Y., Brugarolas, J., Giaccia, A. J., Kurban, G., Pause, A., Frydman, J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0117 · Cited by 161 · see citing works
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161 · see citing works
Self-citationA feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo
Minamishima, Y. A., Moslehi, J., Padera, R. F., Bronson, R. T., Liao, R., & Kaelin, W. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-09 · Cited by 161 · see citing works
Self-citationErythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling
Souma, T., Nezu, M., Nakano, D., Yamazaki, S., Hirano, I., Sekine, H., Dan, T., Takeda, K., Fong, G., Nishiyama, A., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121184 · Cited by 161 · see citing works
Dietary hyperglycemia, glycemic index and metabolic retinal diseases
Chiu, C., & Taylor, A. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.09.001 · Cited by 159 · see citing works
Wozniak, M. B., Calvez‐Kelm, F. L., Abedi‐Ardekani, B., Byrnes, G. B., Durand, G., Carreira, C., Michelon, J., Janout, V., Holcátová, I., Foretová, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057886 · Cited by 154 · see citing works
HIF-1α in Epidermis: Oxygen Sensing, Cutaneous Angiogenesis, Cancer, and Non-Cancer Disorders
Rezvani, H. R., Ali, N., Nissen, L. J., Harfouche, G., de Verneuil, H., Taı̈eb, A., & Mazurier, F. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.141 · Cited by 152 · see citing works
The VHL tumor suppressor and HIF: insights from genetic studies in mice
Kapitsinou, P. P., & Haase, V. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402313 · Cited by 151 · see citing works
Taniguchi, C. M., Finger, E. C., Krieg, A. J., Wu, C., Diep, A. N., LaGory, E. L., Wei, K., McGinnis, L. M., Yuan, J., Kuo, C. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3294 · Cited by 149 · see citing works
Hypoxia-inducible factors as molecular targets for liver diseases
Ju, C., Colgan, S. P., & Eltzschig, H. K. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1408-1 · Cited by 149 · see citing works
HIF1α and HIF2α independently activate SRC to promote melanoma metastases
Hanna, S. C., Krishnan, B., Bailey, S. T., Moschos, S. J., Kuan, P.-F., Shimamura, T., Osborne, L. D., Siegel, M. B., Duncan, L. M., O’Brien, E. T., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66715 · Cited by 147 · see citing works
Self-citationHIF2α cooperates with RAS to promote lung tumorigenesis in mice
Kim, W. Y., Perera, S., Zhou, B., Carretero, J., Yeh, J. J., Heathcote, S. A., Jackson, A. L., Nikolinakos, P., Ospina, B., Naumov, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38443 · Cited by 141 · see citing works
Self-citationThe von Hippel–Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice
Hickey, M. M., Richardson, T., Wang, T., Mosqueira, M., Arguiri, E., Yu, H. D., Yu, Q., Solomides, C., Morrisey, E. E., Khurana, T. S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36362 · Cited by 140 · see citing works
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 141 · see citing works
Regulation of angiogenesis by oxygen sensing mechanisms
Fong, G. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0458-z · Cited by 140 · see citing works
Effects of hypoxia on tumor metabolism
Kim, J., Gao, P., & Dang, C. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9060-4 · Cited by 140 · see citing works
Hypoxia causes triglyceride accumulation via HIF-1-mediated stimulation of lipin 1 expression
Mylonis, I., Sembongi, H., Befani, C. D., Liakos, P., Siniossoglou, S., & Simos, G. (2012) · Journal of Cell Science · doi:10.1242/jcs.106682 · Cited by 137 · see citing works
Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway✰
Lian, G., Li, X., Zhang, L., Zhang, Y., Sun, L., Zhang, X., Liu, H., Pang, Y., Kong, W., Zhang, T., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.041 · Cited by 139 · see citing works
PHD Inhibition Mitigates and Protects Against Radiation-Induced Gastrointestinal Toxicity via HIF2
Taniguchi, C. M., Miao, Y. R., Diep, A. N., Wu, C., Rankin, E. B., Atwood, T. F., Xing, L., & Giaccia, A. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008523 · Cited by 132 · see citing works
HIF2α signaling inhibits adherens junctional disruption in acute lung injury
Gong, H., Rehman, J., Tang, H., Wary, K. K., Mittal, M., Chatturvedi, P., Zhao, Y., Komorova, Y. A., Vogel, S. M., & Malik, A. B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77701 · Cited by 130 · see citing works
Nguyen, A. D., McDonald, J. G., Bruick, R. K., & DeBose‐Boyd, R. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704976200 · Cited by 131 · see citing works
Csák, T., Bala, S., Lippai, D., Satishchandran, A., Catalano, D. E., Kodys, K., & Szabó, G. (2014) · Liver International · doi:10.1111/liv.12633 · Cited by 128 · see citing works
Chen, X., Zhai, B., Koivunen, P., Shin, S. J., Lü, G., Liu, J., Geisen, C., Chakraborty, A. A., Moslehi, J. J., Smalley, D. M., et al. (2014) · Genes & Development · doi:10.1101/gad.242131.114 · Cited by 128 · see citing works
Liu, Y., Ma, Z., Zhao, C., Wang, Y., Wu, G., Xiao, J., McClain, C. J., Li, X., & Feng, W. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.033 · Cited by 126 · see citing works
Ryu, D., Yu, M. R., Kong, K. H., Kim, H., Kwon, S., Jeon, J. S., Han, D. C., & Noh, H. (2019) · Aging Cell · doi:10.1111/acel.12904 · Cited by 126 · see citing works
Kaelin, W. G. (2009) · Cancer · doi:10.1002/cncr.24232 · Cited by 119 · see citing works
Suzuki, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15087 · Cited by 110 · see citing works
Hickey, M. M., Lam, J. C., Bezman, N. A., Rathmell, W. K., & Simon, M. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32614 · Cited by 110 · see citing works
Coenzyme A fuels T cell anti-tumor immunity
Paul, M. S., Saibil, S. D., Han, S., Israni-Winger, K., Lien, S. C., Laister, R. C., Sayad, A., Penny, S. L., Amaria, R. N., Haydu, L. E., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.010 · Cited by 108 · see citing works
Li, L., Zhang, L., Zhang, X., Yan, Q., Minamishima, Y. A., Olumi, A. F., Mao, M., Bartz, S. R., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00282-07 · Cited by 108 · see citing works
Shomento, S., Wan, C., Cao, X., Monier‐Faugere, M., Bouxsein, M., Clemens, T. L., & Riddle, R. C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22396 · Cited by 107 · see citing works
Erythrocytosis and Pulmonary Hypertension in a Mouse Model of Human HIF2A Gain of Function Mutation
Tan, Q., Kerestes, H., Percy, M. J., Pietrofesa, R. A., Chen, L., Khurana, T. S., Christofidou‐Solomidou, M., Lappin, T. R. J., & Lee, F. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444059 · Cited by 104 · see citing works
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
Kaelin, W. G. (2017) · Europe PMC (PubMed Central) · Cited by 102 · see citing works
Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerinPreprint
Wu, C., Rankin, E. B., Castellini, L., Fernandez-Alcudia, J., LaGory, E. L., Andersen, R., Rhodes, S. D., Wilson, T. L. S., Mohammad, K. S., Castillo, A. B., et al. (2015) · Genes & Development · doi:10.1101/gad.255000.114 · Cited by 101 · see citing works
Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype
Cervera, A. M., Apostolova, N., Crespo, F. L., Mata, M., & McCreath, K. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5580 · Cited by 98 · see citing works
Sivaraj, K. K., Dharmalingam, B., Mohanakrishnan, V., Jeong, H., Kato, K., Schröder, S., Adams, S., Koh, G. Y., & Adams, R. H. (2020) · eLife · doi:10.7554/elife.50770 · Cited by 95 · see citing works
Review of angiogenesis in hepatocellular carcinoma
Muto, J., Shirabe, K., Sugimachi, K., & Maehara, Y. (2014) · Hepatology Research · doi:10.1111/hepr.12310 · Cited by 95 · see citing works
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
Li, M., & Kim, W. Y. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01238.x · Cited by 94 · see citing works
Xu, L., Nilsson, M. B., Saintigny, P., Cascone, T., Herynk, M. H., Du, Z., Nikolinakos, P. G., Yang, Y., Prudkin, L., Liu, D., et al. (2010) · Oncogene · doi:10.1038/onc.2010.16 · Cited by 93 · see citing works
HIF2A–LOX Pathway Promotes Fibrotic Tissue Remodeling in Thyroid-Associated Orbitopathy
Hikage, F., Atkins, S., Kahana, A., Smith, T. J., & Chun, T. (2018) · Endocrinology · doi:10.1210/en.2018-00272 · Cited by 86 · see citing works
Kietzmann, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092347 · Cited by 90 · see citing works
Pawlus, M. R., & Hu, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.018 · Cited by 83 · see citing works
Tumor-suppressor genes, cell cycle regulatory checkpoints, and the skin
Vélez, A. M. A., & Howard, M. S. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.157476 · Cited by 83 · see citing works
Gao, R. Y., Wang, M., Liu, Q., Feng, D., Wen, Y., Xia, Y., Colgan, S. P., Eltzschig, H. K., & Ju, C. (2019) · Hepatology · doi:10.1002/hep.30954 · Cited by 79 · see citing works
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer
Jackson, A. L., Zhou, B. R., & Kim, W. Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.511617 · Cited by 79 · see citing works
Russell, R. C., Sufan, R. I., Zhou, B. R., Heir, P., Bunda, S., Sybingco, S. S., Greer, S. N., Roche, O., Heathcote, S. A., Chow, V. W. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2370 · Cited by 78 · see citing works
Zhang, S., Dong, Y., Wang, P., Zhang, X., Yan, Y., Sun, L., Liu, B., Zhang, D., Zhang, H., Liu, H., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.022 · Cited by 74 · see citing works
Hypoxia downregulates protein S expression
Pilli, V. S. S., Datta, A., Afreen, S., Catalano, D. E., Szabó, G., & Majumder, R. (2018) · Blood · doi:10.1182/blood-2018-04-841585 · Cited by 74 · see citing works
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
Zhou, B. R., Damrauer, J. S., Bailey, S. T., Hadzic, T., Jeong, Y., Clark, K. S., Fan, C., Murphy, L. L., Lee, C. Y., Troester, M. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69804 · Cited by 70 · see citing works
DeBerge, M., Lantz, C. W., Dehn, S., Sullivan, D. P., van der Laan, A. M., Niessen, H. W. M., Flanagan, M. E., Brat, D. J., Feinstein, M. J., Kaushal, S., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200667 · Cited by 68 · see citing works
Multitasking by pVHL in tumour suppression
Frew, I. J., & Krek, W. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.001 · Cited by 68 · see citing works
Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
Lefere, S., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., Devisscher, L., & Geerts, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2222-1 · Cited by 68 · see citing works
Wang, P., Zeng, G., Yan, Y., Zhang, S., Dong, Y., Zhang, Y., Zhang, X., Liu, H., Zhang, Z., Jiang, C., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.001 · Cited by 63 · see citing works
GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells
Arroyo, N., Villamayor, L., Díaz, I., Carmona, R., Ramos-Rodríguez, M., Muñoz-Chápuli, R., Pasquali, L., Toscano, M. G., Martín, F., Cano, D. A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150059 · Cited by 60 · see citing works
New Insights into the Biology of Renal Cell Carcinoma
Li, L., & Kaelin, W. G. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.04.004 · Cited by 62 · see citing works
SIRT1 attenuates renal fibrosis by repressing HIF-2α
Li, P., Liu, Y., Qin, X., Chen, K., Wang, R., Yuan, L., Chen, X., Hao, C., & Huang, X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00443-x · Cited by 57 · see citing works
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis
Criscimanna, A., Duan, L.-J., Rhodes, J., Fendrich, V., Wickline, E., Hartman, D., Monga, S., Lotze, M., Gittes, G., Fong, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0566 · Cited by 51 · see citing works
Targeting HIF2 in Clear Cell Renal Cell CarcinomaPreprint
Cho, H., & Kaelin, W. G. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030833 · Cited by 56 · see citing works
- Authors
- Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- University of Vermont (US)
- Harvard University (US)
- Corresponding author
- Kaelin, William G
- ORCID
- Venue
- The EMBO Journal
- Published
- 2006-09-14
- Volume
- 25
- Issue
- 19
- Pages
- 4650-4662
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1589988
- OpenAlex
- W2097654747
- Cited by
- 235
- References
- 58
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 13 · 2023: 11 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 13 · 2017: 6 · 2016: 10 · 2015: 10 · 2014: 25 · 2013: 14 · 2012: 12
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Cancer Institute (T32CA009172)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- von Hippel-Lindau tumor suppressor, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, prolyl hydroxylation, phenocopy, Rosa26 locus, Cre-loxP system, liver, skin, HIF target genes, gene expression profiling, tumor suppressor inactivation
- MeSH terms
- Epidermal Cells, Endothelial PAS Domain-Containing Protein 1, Animals, Blood Vessels, Body Weight, Epidermis, Gene Expression Regulation, HeLa Cells, Humans, Hydroxylation, Liver, Mice, Inbred BALB C, Mice, Mutant Strains, Organ Size, Phenotype, Proline, Recombination, Genetic, Hepatocytes, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
